Chronic pancreatitis, a distressing ailment, often necessitates significant surgery for pancreas removal. UC’s recent study on patients undergoing this surgery reveals that approximately two-thirds survive a decade post-surgery, yet over a quarter still rely on daily opioid use for pain, according to findings presented at the Southern Surgical Association’s annual meeting and published in the Journal of the American College of Surgeons. The study, encompassing 493 patients from UC Medical Center (2000-2020), stresses the need for extended post-surgery care, emphasizing that survival declines even five years after intervention.
Gregory Wilson, MD, the lead author, underscores the expectation to restore patients’ normal lives after surgery, but the study indicates continued survival decline beyond five years post-surgery. Media coverage, including U.S. News & World Report, highlights the gravity of chronic pancreatitis and the imperative for long-term patient care, extending beyond annual primary care visits.
Wilson advocates for ongoing care, addressing physical health conditions like diabetes and providing psychological counseling for potential addiction. Chronic pancreatitis, marked by persistent inflammation affecting normal organ function, presents risks tied to heavy drinking and smoking. Patients often endure weight loss, diarrhea, and diabetes, with chronic abdominal pain being a prevalent and debilitating symptom, leading to prolonged painkiller usage.
Surgery, while potentially improving life quality, doesn’t eliminate the need for continued care, as patients may remain opioid-dependent even after the procedure.
